The British newspaper Daily Express apologized to the Russian Direct Investment Fund (RDIF) for an article claiming that the development of the British-Swedish company AstraZeneca was used to create the Sputnik V coronavirus vaccine, allegedly at the disposal of the Russian special services.
“This article contained false information. As an apology, we are happy to post the RDIF statement, “- stated in publications…
In the statement of the fund, which the publication cites, it is said that the developers of “Sputnik V” for many years have used one platform using human adenoviruses. In particular, this approach was used back in 2017 when creating a Russian drug for Ebola. The British-Swedish company is using a chimpanzee adenovirus vector for its vaccine, rather than a human vector, the foundation explained.
Earlier, on October 10, The Sun also published material about the theft of the AstraZeneca formula. The article of the British tabloid was commented on by the press secretary of the President of the Russian Federation Dmitry Peskov, calling The Sun “a deeply unscientific newspaper.”
Later, The Sun released a revised version of the text with quotations from the RDIF statement, adding “Gazeta.ru“.
RDIF called the article fake news and blatant lies based on anonymous sources. The Foundation explained that such publications have no scientific meaning.
The Russian drug “Sputnik V” was developed by the specialists of the Gamaleya Center. It was registered in August 2020 and became the first vaccine against COVID-19 in the Russian Federation and the world. Also, four more vaccines against coronavirus have been registered in the country: Sputnik Light, EpiVacCorona, EpiVacCorona-N and KoviVac. Free large-scale coronavirus vaccination in the country has been taking place since January.
All relevant information on the situation with the coronavirus is available on the websites stopcoronavirus.rf and access to all.rf, as well as the hashtag #WeWe areTogether. Coronavirus hotline: 8 (800) 2000-112.